Aleix Prat

4 articles listing Aleix Prat in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial Nature Communications
2. Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO) Nature Communications
3. HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy Nature Communications
4. Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 Nature Communications